|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.540 USD | -0.39% |
|
+3.25% | -11.50% |
| 11-11 | Deutsche Bank Raises Price Target on Definitive Healthcare to $6 From $5, Keeps Hold Rating | MT |
| 11-07 | Definitive Healthcare Corp., Q3 2025 Earnings Call, Nov 06, 2025 |
| Capitalization | 262M 225M 209M 195M 364M 23.65B 390M 2.41B 946M 11.31B 984M 964M 41.48B | P/E ratio 2025 * |
-1.86x | P/E ratio 2026 * | -15.2x |
|---|---|---|---|---|---|
| Enterprise value | 240M 205M 191M 178M 333M 21.63B 357M 2.2B 865M 10.35B 900M 881M 37.94B | EV / Sales 2025 * |
1x | EV / Sales 2026 * | 0.93x |
| Free-Float |
30.36% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Definitive Healthcare Corp.
| 1 day | -0.39% | ||
| 1 week | +3.25% | ||
| Current month | -11.50% | ||
| 1 month | +9.96% | ||
| 3 months | -11.50% | ||
| 6 months | -35.20% | ||
| Current year | -11.50% |
| 1 week | 2.46 | 2.66 | |
| 1 month | 2.24 | 2.88 | |
| Current year | 2.34 | 2.87 | |
| 1 year | 2.15 | 5.68 | |
| 3 years | 2.15 | 14.03 | |
| 5 years | 2.15 | 50.3 | |
| 10 years | 2.15 | 50.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kevin Coop
CEO | Chief Executive Officer | 61 | 24/06/2024 |
Casey Heller
DFI | Director of Finance/CFO | 37 | 02/06/2025 |
Ben Graboske
CTO | Chief Tech/Sci/R&D Officer | 56 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jason Krantz
CHM | Chairman | 53 | 01/02/2011 |
Jeff Haywood
BRD | Director/Board Member | 47 | 01/02/2015 |
Lauren Young
BRD | Director/Board Member | 43 | 01/07/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.39% | +3.25% | -39.81% | -78.80% | 262M | ||
| -0.44% | +0.92% | +13.90% | +100.07% | 3,547B | ||
| +1.08% | +3.09% | +166.74% | +2,459.34% | 428B | ||
| +1.57% | +7.94% | +8.30% | +60.14% | 102B | ||
| +1.27% | +8.63% | +106.86% | +2,609.47% | 91.31B | ||
| -0.55% | +8.06% | +8.87% | +93.69% | 88.6B | ||
| -1.45% | -5.86% | +21.52% | +125.40% | 77.9B | ||
| +4.71% | -5.33% | +24.10% | +131.22% | 53.85B | ||
| -0.71% | -3.26% | +39.37% | +138.68% | 46B | ||
| +0.01% | -4.83% | -39.58% | -0.03% | 38.53B | ||
| Average | -0.22% | +1.32% | +31.03% | +563.92% | 447.27B | |
| Weighted average by Cap. | -0.32% | +1.31% | +30.24% | +376.16% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 240M 205M 191M 178M 332M 21.59B 356M 2.2B 864M 10.33B 898M 880M 37.87B | 234M 200M 186M 173M 324M 21.05B 348M 2.14B 842M 10.07B 876M 858M 36.93B |
| Net income | -162M -139M -129M -121M -225M -14.64B -242M -1.49B -586M -7B -609M -597M -25.67B | -19.11M -16.36M -15.22M -14.19M -26.51M -1.72B -28.43M -175M -68.91M -824M -71.66M -70.19M -3.02B |
| Net Debt | -22.44M -19.22M -17.87M -16.66M -31.13M -2.02B -33.39M -206M -80.92M -968M -84.16M -82.43M -3.55B | -44.56M -38.15M -35.48M -33.08M -61.81M -4.02B -66.3M -409M -161M -1.92B -167M -164M -7.04B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/01/26 | 2.540 $ | -0.39% | 252,895 |
| 09/01/26 | 2.550 $ | -0.78% | 327,510 |
| 08/01/26 | 2.570 $ | +0.39% | 257,021 |
| 07/01/26 | 2.560 $ | +0.79% | 465,496 |
| 06/01/26 | 2.540 $ | +3.25% | 467,514 |
Delayed Quote Nasdaq, January 13, 2026 at 12:00 am
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DH Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















